- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04375072
Home-based tDCS and Mindfulness-based Meditation for Self-management of Clinical Pain and Symptoms
October 27, 2025 updated by: Hyochol Ahn, University of Arizona
Combination Therapy of Home-based Transcranial Direct Current Stimulation and Mindfulness-based Meditation for Self-management of Clinical Pain and Symptoms in Older Adults With Knee Osteoarthritis
This clinical trial aims to evaluate whether a 2 week regimen of transcranial direct current stimulation (tDCS) paired with mindfulness-based meditation (MBM) can improve pain modulation, reduce clinical pain, and alleviate osteoarthritis (OA)-related symptoms in patients with knee OA.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
208
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arizona
-
Tucson, Arizona, United States, 85721
- University of Arizona
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- have symptomatic knee OA based on American College of Rheumatology clinical criteria
- have had knee OA pain in the past 3 months with an average of at least 30 on a 0-100 NRS for pain,
- can speak and read English
- have no plan to change medication regimens for pain throughout the trial
Exclusion Criteria:
- history of brain surgery, brain tumor, seizure, stroke, or intracranial metal implantation
- systemic rheumatic disorders, including rheumatoid arthritis,systemic lupus erythematosus, and fibromyalgia
- alcohol/substance abuse
- diminished cognitive function that would interfere with understanding study procedures (i.e., Mini-Mental Status Exam score ≤ 23)
- pregnancy or lactation
- prosthetic knee replacement or non-arthroscopic surgery to the affected knee
- hospitalization within the preceding year for psychiatric illness
- no access to a device that can be used for secure videoconferencing for real-time remote supervision.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: active tDCS paired with active MBM,
|
Active tDCS with a constant current intensity of 2 milli ampere (mA) will be applied for 20 minutes per session daily for 2 weeks via the Soterix 1x1 tDCS mini-CT Stimulator device with headgear and saline-soaked surface sponge electrodes.
The meditation intervention will be applied simultaneously with tDCS for 20 minutes per session daily for 2 weeks by a recorded meditation.
|
|
Active Comparator: sham tDCS paired with active MBM
|
For sham stimulation, the electrodes will be placed in the same positions as for active stimulation, but the stimulator will only deliver 2 mA current for 30 seconds during each 20-minute session, conducted daily for 2 weeks.
The meditation intervention will be applied simultaneously with tDCS for 20 minutes per session daily for 2 weeks by a recorded meditation.
|
|
Active Comparator: active tDCS paired with sham MBM
|
Active tDCS with a constant current intensity of 2 milli ampere (mA) will be applied for 20 minutes per session daily for 2 weeks via the Soterix 1x1 tDCS mini-CT Stimulator device with headgear and saline-soaked surface sponge electrodes.
The sham MBM intervention will be delivered via a CD player that will look identical in both active and sham MBM.
|
|
Sham Comparator: sham tDCS paired with sham MBM
|
For sham stimulation, the electrodes will be placed in the same positions as for active stimulation, but the stimulator will only deliver 2 mA current for 30 seconds during each 20-minute session, conducted daily for 2 weeks.
The sham MBM intervention will be delivered via a CD player that will look identical in both active and sham MBM.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Numeric Rating Score (NRS) of Pain
Time Frame: baseline, week 2 (after 10 tDCS sessions)
|
The Numeric Rating Scale (NRS) is a subjective measure of pain intensity.
The NRS total score ranges from 0 (no pain) to 100 (most intense pain imaginable).
Change in NRS = Week 2 (post-intervention) NRS - Baseline (pre-intervention) NRS.
A decrease in NRS score indicates improvement.
|
baseline, week 2 (after 10 tDCS sessions)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC).
Time Frame: baseline, week 2 (after 10 tDCS sessions)
|
Change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): 26 question index to assess knee OA pain (0-20 scale), function (0-68 scale), and stiffness (0-8 scale).
The total WOAMC score is the sum of the 3 sub scales for a total score range from 0-96.
Change in total WOMAC score = Week 2 total WOMAC score - Baseline (pre-intervention) total WOMAC score.
The lower change scores represents improvement in pain, movement, and stiffness.
|
baseline, week 2 (after 10 tDCS sessions)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Hyochol Ahn, PhD,RN,MSN, University of Arizona
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 13, 2020
Primary Completion (Actual)
January 30, 2025
Study Completion (Actual)
January 30, 2025
Study Registration Dates
First Submitted
April 30, 2020
First Submitted That Met QC Criteria
April 30, 2020
First Posted (Actual)
May 5, 2020
Study Record Updates
Last Update Posted (Actual)
November 12, 2025
Last Update Submitted That Met QC Criteria
October 27, 2025
Last Verified
October 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00003164
- R01NR019051 (U.S. NIH Grant/Contract)
- R01NR019051-03S1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteo Arthritis Knee
-
Gillian HatfieldLes Mills InternationalActive, not recruitingOsteo Arthritis Knee and HipCanada
-
University of PaviaNot yet recruitingLower Limb Arthroplasty: Effects of a Tele Prehabilitation Program With Indirect Electrostimulation.Osteo Arthritis Knee and Hip | Lower Limb ArthroplastyItaly
-
University of JaénActive, not recruiting
-
University of PaviaActive, not recruitingOsteo Arthritis KneeItaly
-
NHS LothianRecruitingOsteo Arthritis Knee | Arthropathy of Knee | Arthritis KneeUnited Kingdom
-
Golden Jubilee National HospitalJohnson & Johnson; DePuy OrthopaedicsNot yet recruitingOsteoarthritis | Knee Osteoarthritis | Osteoarthritis (OA) | Osteo Arthritis | Osteoarthritis in the Knee | Osteoarthritis (Knee) | Osteo Arthritis of the KneeUnited Kingdom
-
Anchen Pharmaceuticals, IncNovum Pharmaceutical Research ServicesCompletedOsteo Arthritis of the KneeUnited States
-
Prince Sattam Bin Abdulaziz UniversityCompleted
-
Science and Research Centre KoperSlovenian Research AgencyCompletedOsteo Arthritis Knee | Knee ArthroplastySlovenia
-
Medacta USACompletedOsteo Arthritis Knee | Total Knee ArthroplastyUnited States
Clinical Trials on active tDCS paired with active MBM
-
Florida State UniversityCompletedOsteoarthritis, KneeUnited States
-
University of ArizonaRecruitingAlzheimer&Amp;#39;s Disease | Other DementiasUnited States
-
Tianjin Anding HospitalChinese Academy of SciencesEnrolling by invitationSchizophrenia Negative TypeChina
-
William Beaumont HospitalsWithdrawnChronic Pain | Pelvic PainUnited States
-
William Beaumont HospitalsWithdrawnChronic Pelvic PainUnited States
-
The University of Texas at DallasWithdrawn
-
Florida State UniversityRecruiting
-
Bambino Gesù Hospital and Research InstituteCompleted
-
Shanghai Mental Health CenterRecruitingObsessive-Compulsive DisorderChina
-
Bambino Gesù Hospital and Research InstituteEnrolling by invitationDevelopmental DyslexiaItaly